|
Karin Eastham has been an Illumina Board of Director since August 2004. Ms. Eastham is currently Executive Vice President Chief Operating Officer and a member of the Board of Trustees of The Burnham Institute for Medical Research. She also serves as Board of Director for Amylin Pharmaceuticals Tercica SGX Pharmaceuticals and Cyntellect. Prior to joining The Burnham Institute in 2004 Ms. Eastham was Senior Vice President Chief Financial Officer and Secretary of Diversa Corporation. She previously held similar positions with CombiChem Inc. Cytel Corporation and Boehringer Mannheim Diagnostics.
Karin received both bachelor of science and master of business administration degrees from Indiana University and is a Certified Public Accountant. | 